Stay updated on CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.

Latest updates to the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNew sections provide guidance on reading the study record and joining the study. The recruitment status now indicates that no participants are being sought, and the Intervention/Treatment heading formatting has been adjusted.SummaryDifference0.5%

- Check16 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the record's metadata. No changes to the study data or eligibility criteria are implied.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page shows Revision: v3.5.4, replacing v3.5.3, indicating a deployment update.SummaryDifference0.1%

- Check59 days agoChange DetectedThe update changes the site’s footer revision/version indicator from v3.5.2 to v3.5.3, with no apparent changes to the study details shown on the page.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 in the site footer, indicating a minor backend/UI update.SummaryDifference0.1%

Stay in the know with updates to CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.